The company
Cellectar Biosciences, Inc.
CLRB · Nasdaq
CLRB stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 55.6% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 52
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $100K
- Insider sales, 12 months
- $733
- Officials’ trades on record
- 0
- Institutions holding
- 28 (+9)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| James V. CarusoChief Executive Officer | bought | 8,680at $2.88 | 7 May 2026filed 11 May 2026 |
| James V. CarusoChief Executive Officer | bought | 26,040at $0.01 | 7 May 2026filed 11 May 2026 |
| Jarrod LongcorChief Operating Officer | bought | 8,680at $2.88 | 7 May 2026filed 11 May 2026 |
| Jarrod LongcorChief Operating Officer | bought | 26,040at $0.01 | 7 May 2026filed 11 May 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Caligan Partners LPnew · filed 14 Aug 2026 | 469,998$1.3M | +469,998 |
| STEMPOINT CAPITAL LPnew · filed 14 Aug 2026 | 354,938$987K | +354,938 |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 327,367$910K | +245,483+299.8% |
| SILVERARC CAPITAL MANAGEMENT, LLCnew · filed 13 Aug 2026 | 321,728$894K | +321,728 |
| Bleichroeder LPadded · filed 13 Aug 2026 | 288,679$803K | +188,679+188.7% |
| Jupiter Topco LLCnew · filed 14 Aug 2026 | 274,156$759K | +274,156 |
| Balyasny Asset Management L.P.new · filed 14 Aug 2026 | 220,000$612K | +220,000 |
| Nantahala Capital Management, LLCnew · filed 14 Aug 2026 | 219,998$612K | +219,998 |
| Empery Asset Management, LPnew · filed 11 Aug 2026 | 189,605$527K | +189,605 |
| DIADEMA PARTNERS LPnew · filed 14 Aug 2026 | 138,341$385K | +138,341 |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.